ARKG — ARK Genomic Revolution ETF

—
BTS · Health Care · Developed Markets · CIK ·
Last close
—
Market Cap
—
52W High
—
52W Low
—
ADV30
—
Next earnings
—
The investment seeks long-term growth of capital. The fund is an actively-managed exchange-traded fund ("ETF") that will invest under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors, including healthcare, information technology, materials, energy and consumer discretionary, that are relevant to the fund's investment theme of the genomics revolution ("Genomics Revolution Companies"). It is non-diversified.
No quarterly fundamentals indexed for this ticker.

Max Pain — expiry 2028-01-21

max pain strike: $48.00 · spot: $41.26 · call oi: 778 · put oi: 4,555
Expected Move to 2028-01-21: ±$18.02 (43.67%) — implied range $23.24 – $59.28 · ATM straddle on $41.00 strike

News headlines (Yahoo Finance, 1h cache)

Cathie Wood Loads Up On TEM, ILMN And Biotech Stocks — But Pares Stake In This Pharma Giant That Had A Blowout Q3
2026-10-31 05:05 · Yahoo
Cathie Wood-Led Ark Invest Sells AMD, SPCX, GOOG Stocks — But Loads Up On CMPS, NTLA, CRSP And Other Healthcare Firms
2026-10-10 06:02 · Yahoo
Do You Own Tempus AI Without Knowing It? Check These ETFs After Its Earnings Surge
2026-11-02 19:54 · Yahoo
Cathie Wood Bought More CRISPR Therapeutics Stock 2 Days in a Row. Here's What She Sees in the Biotech Stock.
2026-10-18 11:10 · Yahoo
Best ETF Areas of June
2026-07-06 12:00 · Yahoo
3 ETFs For the Coming Genomics Revolution
2026-06-07 12:45 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.